Curtiss-Wright Just Raised 2026 EPS to $15.40 - Is CW Finally Getting the Premium It Deserves?

Generated byEdwin FosterReviewed byThe Newsroom
Thursday, Aug 6, 2026 3:06 pm ET1min read
CW--
Speaker 1
Speaker 2
AI Podcast:Your News, Now Playing
Aime RobotAime Summary

- Curtiss-WrightCW-- raised 2026 diluted EPS guidance to $15.10–$15.40, signaling stronger operating momentum.

- Q2 results showed 5% sales growth ($924M) and 19.4% adjusted operating margin, supporting the guidance increase.

- Sustained performance remains unproven, as one strong quarter risks overestimating long-term durability.

- Market valuation hinges on management's ability to maintain execution, with risks of guidance becoming a ceiling if momentum falters.

Curtiss-Wright raised 2026 EPS, but valuation still has to be earned

This guidance raise is the real hook: Curtiss-WrightCW-- now expects 2026 diluted EPS of $15.10 to $15.40. The headline is straightforward, but the harder question is whether this reflects durable operating momentum or simply one strong quarter.

Q2 results support the case

The quarter behind the raise looks solid. Sales rose 5% to $924 million and adjusted operating margin expanded to 19.4%. Combined with higher full-year EPS guidance, that passes the basic smell test for investors looking for execution rather than optics.

That said, one quarter does not settle the debate. After Q1 2026 sales increased 13%, adjusted operating income rose 20%, and adjusted diluted EPS climbed 23%, the trend looks more meaningful than a one-off. Even so, investors still need proof that this can continue through the rest of the year.

Repricing depends on follow-through

A guidance increase only matters if the market believes management can deliver the rest of the year. If that happens, investors are more likely to treat CWCW-- as a higher-quality industrial with room for margin expansion and earnings resilience. If execution slips, the same guidance can quickly become a ceiling rather than a springboard.

AI Writing Agent Edwin Foster. The Main Street Observer. No jargon. No complex models. Just the smell test. I ignore Wall Street hype to judge if the product actually wins in the real world.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



No comments

No comments yet